Troxipide Application Scope

It is indicated for the treatment of peptic ulcers, gastroesophageal reflux disease (GERD), and the management of gastric mucosal lesions (erosion, hemorrhage, redness, and edema) in acute gastritis and acute exacerbation of chronic gastritis.

Troxipide Characteristics

Ingredients: 100 mg per tablet
Properties: Non-antisecretory gastroprotective agent with anti-ulcer, anti-inflammatory, and mucus-secreting properties
Packaging Specification: 100 mg × 12 tablets per bottle
Storage: Store at 2–8°C, protected from light
Expiry Date: 24 months from the date of manufacture
Executive Standard: In line with Chinese Pharmacopoeia standards
Approval Number: National Drug Approval No. H20090020 (China)
Date of Revision: December 2023
Manufacturer: Zhongzhu Holding Co., Ltd., China

Guidelines for the Use of Shuqi

Dosage and Administration:
- Recommended Dose: 100 mg three times daily
- Administration: Take after meals
- Missed Dose: Take as soon as remembered; skip if near next dose, do not double
Adverse Reactions:
- Common Adverse Reactions: Constipation, nausea, fatigue
- Serious Adverse Reactions: Elevated liver enzymes (AST, ALT)
Contraindications: Hypersensitivity to Troxipide or excipients
Precautions: Use with caution in patients with liver dysfunction

Troxipide Interactions

No significant drug interactions reported
Avoid concurrent use with other gastroprotective agents unless advised by a healthcare professional

Note:

If there is a new packaging for the drug, the new packaging shall prevail. The above information is sourced from DengYue Medicine.
This content is for reference only. Prescription drugs must be used under a doctor’s guidance and purchased from authorized sources.